{"url":"https://lda.senate.gov/api/v1/filings/cf0ea7e4-92cc-443e-bd3e-bb8976f6ea74/","filing_uuid":"cf0ea7e4-92cc-443e-bd3e-bb8976f6ea74","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2013,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cf0ea7e4-92cc-443e-bd3e-bb8976f6ea74/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Marianne Casserly, Partner","dt_posted":"2013-07-22T20:02:03.287000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"THE ATLANTIC BUILDING","registrant_address_2":"950 F STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1182,"url":"https://lda.senate.gov/api/v1/registrants/1182/","house_registrant_id":31748,"name":"ALSTON & BIRD LLP","description":"Law Firm","address_1":"THE ATLANTIC BUILDING","address_2":"950 F STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM J. BIEGEL","contact_telephone":"+1 202-239-3692","dt_updated":"2026-07-20T16:02:02.800694-04:00"},"client":{"id":102486,"url":"https://lda.senate.gov/api/v1/clients/102486/","client_id":1006257,"name":"PACKAGING COORDINATORS, INC.","general_description":"Pharmaceutical packaging","client_government_entity":false,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-11"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Efforts to clarify that contract packagers should not be subject to Generic Drug User Fee Act facility fees.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54597,"prefix":null,"prefix_display":null,"first_name":"CATHY","nickname":null,"middle_name":null,"last_name":"BURGESS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":40770,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"L","last_name":"BUTLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}